Switch View
© PR Newswire
01.10.2025
ISIN: US2290503075
Cryoport Inc
CYRX
LISTED
NASDAQ
Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France
News Preview
The 55,000-Square-Foot Facility is the Latest Addition to Cryoport Systems' Global Supply Chain Center Network
Designed to Support Complex Life Sciences Supply Chain Needs, Including Biologistics, BioServices and Future Cryopreservation Services Worldwide...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology to Announce Third Quarter 2025 Results on October 29, 2025
News Preview
Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2025 financial results on Wednesd...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare to announce third quarter 2025 results on October 29, 2025
News Preview
GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://invest...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
01.10.2025
ISIN: US91324P1021
UnitedHealth Group Inc
UNH
LISTED
NYSE
UnitedHealthcare’s 2026 Medicare Advantage Plans Deliver Value, Access and Consumer Choice
News Preview
UnitedHealthcare® today introduced its 2026 Medicare Advantage plans, offering reliable coverage and benefits to meet the evolving needs of Medicare consumers. With more than 45 years of experience in serving Medicare beneficiaries and nearly two decades as the most chosen Medicare Advantage brand1, UnitedHealthcare remains focused on delivering v...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
01.10.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune, Inc. (NASDAQ: ALT) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
News Preview
PHILADELPHIA, Oct. 1, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Altimmune Inc. (NASDAQ: ALT) ("Altimmune" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of Altimmune between August 10, 202...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics (MLTX) Faces Investor Scrutiny After Reporting Disappointing Phase 3 Trial Data For Lead Drug Candidate -- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 1, 2025 /PRNewswire/ -- Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) saw the price of their shares crater $55.75, or about 90%, after the company announced disastrous VELA-2 trial results for sonelokimab, its highly anticipated treatment for patients with skin disease (hidradenitis...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
01.10.2025
ISIN: CA3686501071
Gemina Laboratories Ltd
GLAB
LISTED
CSE
Gemina Laboratories Announces Termination of Transaction
News Preview
VANCOUVER, BC / ACCESS Newswire / October 1, 2025 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") announces that further to its news release dated November 13, 2024, the Company will not be proceeding with the non-brokered private placement of up to $7,000,000 at a price of $0.75 per common share. The Company h...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Avantor® to Host Third Quarter 2025 Earnings Call on Wednesday, October 29, 2025
News Preview
RADNOR, Pa., Oct. 1, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its third quarter 2025 financial results before the market opens on Wednesd...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US81749D1072
Sera Prognostics Inc
SERA
LISTED
NASDAQ
Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer
News Preview
SALT LAKE CITY, Oct. 1, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker testing to help deliver information to doctors and patients, today announced the appointment of Tiffany Inglis, M...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
BUYOUT INVESTIGATION: Does $28.00 Per Share Buyout Offer Shortchange STAAR Surgical Company (NASDAQ: STAA) Shareholders? Kaskela Law LLC is Investigating the Buyout Offer and Encourages STAA Shareholders to Contact the Firm
News Preview
PHILADELPHIA, Oct. 1, 2025 /PRNewswire/ -- The law firm of Kaskela Law LLC announces that it is investigating the shareholder buyout offer made to STAAR Surgical Company (NASDAQ: STAA) ("STAAR" or the "Company") investors to determine whether the proposal is fair and provides sufficient monetary consideration for...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: GB00BRS65X63
Indivior plc
INDV
LISTED
LSE
Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation
News Preview
RICHMOND, Va., Oct. 1, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) ("Indivior PLC" or the "Company") today announced that it intends to pursue a change in domicile from the U.K. to the U.S. and will establish a new U.S. parent company, Indivior Pharmaceuticals, Inc. (IPI), above its existing U.K. parent comp...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US28414H1032
Elanco Animal Health Inc
ELAN
LISTED
NYSE
Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement
News Preview
GREENFIELD, Ind., Oct. 1, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2025 financial results on Wednesday, November 5, 2025. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's perfor...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
01.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
Natrelle® Awarded Supplier Agreement from Vizient
News Preview
This agreement grants Vizient clients enhanced access to Natrelle®, the broadest selection of breast implant options on the market.
IRVINE, Calif., Oct. 1, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that Natrelle® has been named a supplier by Vizient,...
Themefolio
Profiler
Peergroup
© Newsfile
01.10.2025
ISIN: CA71716H1082
PharmaTher Holdings Ltd.
PHRM
LISTED
CSE
PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate over US$25 Million in Milestone and Profit-Sharing Payments
News Preview
Toronto, Ontario--(Newsfile Corp. - October 1, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce that it has entered into a definitive Asset Purchase Agreement (the "Agreement") for the...
Themefolio
Profiler
Peergroup
© Newsfile
01.10.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - October 1, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that management will participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) conferen...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2025 before the market opens on Wednesday, October 22, 2025, and will hold a conference call on the same day at 8:30 a.m. ET.
During the call, the company will discuss its financial performanc...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf and The Baldwin Fund Partner to Raise Funds for Breast Cancer Research This October
News Preview
Curaleaf celebrates six years of its national at-register donation program for Breast Cancer Action Month
All contributions benefit The Carol M. Baldwin Breast Cancer Research Fund of CNY, also known as The Baldwin Fund...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf and The Baldwin Fund Partner to Raise Funds for Breast Cancer Research This October
News Preview
Curaleaf celebrates six years of its national at-register donation program for Breast Cancer Action Month
All contributions benefit The Carol M. Baldwin Breast Cancer Research Fund of CNY, also known as The Baldwin Fund...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: INE376G01013
Biocon Ltd
BIOCON
LISTED
Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars
News Preview
BENGALURU, India and BRIDGEWATER, N.J., Oct. 1, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON), today announced a settlement and license agreement with Amgen Inc. that clears the path for the commercializatio...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US02043Q1076
Alnylam Pharmaceuticals Inc
ALNY
LISTED
NASDAQ
Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of Zilebesiran
News Preview
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the first patient has been dosed in ZENITH (ZilebEsiraN CardIovascular OuTcome Study in Hypertension), a global Phase 3 cardiovascular outcomes trial (CVOT) designed to evaluate the potential of zilebesiran, an investigational biannual subcuta...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US5898891040
Merit Medical Systems Inc
MMSI
LISTED
NASDAQ
Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
News Preview
SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US98160J1088
MariMed Inc.
MRMD
LISTED
CSE
MariMed’s InHouse Brand Again Supports Veterans Facing Housing Challenges With Second Annual Help on the Homefront Campaign
News Preview
MariMed’s InHouse Brand Again Supports Veterans Facing Housing Challenges With Second Annual Help on the Homefront Campaign...
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer Expands Wertheim Site with new Production Facility for Ready-to-fill Vials
News Preview
Gerresheimer Expands Wertheim Site with new Production Facility for Ready-to-fill Vials
New production hall for RTF vials and innovative EZ-fill Smart packaging platform
Best possible protection for sensitive biologics
Total investment volume of around EUR 30 million
Around 50 new jobs for skilled workers from the region
Düsseldorf/Wertheim, Ge......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer erweitert Standort Wertheim für die Produktion von „ready-to-fill“ Injektionsfläschchen
News Preview
Gerresheimer erweitert Standort Wertheim für die Produktion von „ready-to-fill“ Injektionsfläschchen
Neue Produktionshalle für RTF-Fläschchen und innovative Verpackungsplattform EZ-fill Smart
Bestmöglichen Schutz für empfindliche Biopharmazeutika
Gesamtinvestitionsvolumen von rund 30 Mio. Euro
Rund 50 neue Arbeitsplätze für Fachkräfte aus de......
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care
News Preview
Providing access to affordable care
$0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1,
$0 copay for colonoscopies and mammograms...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
News Preview
Commercial Focus Remains on U.S. Market as it Continues to Explore Certain Global Markets that Accept FDA Cleared Devices ...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: JE00BYSS4X48
Novocure Ltd
NVCR
LISTED
NASDAQ
Novocure to Report Third Quarter 2025 Financial Results
News Preview
Novocure (NASDAQ: NVCR) will report financial results for the third quarter 2025 on October 30, 2025, before the U.S. financial markets open.
Novocure management will host a conference call and webcast at 8:00 a.m. EDT, October 30, to discuss the company’s financial results for the three- and nine-month periods that ended September 30, 2025.
T...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana’s 2026 Medicare Advantage Plans Prioritize Simplicity, Stability and Quality Care for Beneficiaries
News Preview
Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2026. During the Medicare Annual Election Period (AEP) Oct. 15-Dec. 7, Medicare beneficiaries may review plan changes for the coming year and select a plan to meet their evolving healthcare need...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: JP3475350009
Daiichi Sankyo Co Ltd
45680
LISTED
XJPX
ENHERTU® Followed by THP Supplemental Biologics License Application Accepted in the U.S. for Patients with High-Risk HER2 Positive Early-Stage Breast Cancer Prior to Surgery
News Preview
Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) has been accepted for review in the U.S. for the neoadjuvant treatment of adult patients with HER2 positive (IHC 3+ or ISH+) sta...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to BMS-986446, a potential best-in-class anti-microtubule binding region-tau (anti-MTBR-tau) antibody currently in Phase 2 development for the treatment of early Alzheimer’s disease. Fast Track Designation is intende...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2025 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, Oct. 30. During the call, company executives will provide an overview of Merck’s performance for the quarter.
Investors, journalists an...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US05479K1060
Elutia Inc
AZYO
LISTED
NASDAQ
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
News Preview
- Strengthened balance sheet to fully fund development and launch of NXT-41 platform -...
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2025
ISIN: US4525EP1011
Immunic Inc
IMUX
LISTED
NASDAQ
Immunic to Participate in Scientific and Investor Conferences in October
News Preview
Immunic to Participate in Scientific and Investor Conferences in October
NEW YORK, October 1, 2025 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following scientific and in......
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: AU000000AVH4
Avita Medical Inc.
AVH
LISTED
ASX
CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
News Preview
CMS grants NTAP for RECELL, adding up to $4,875 reimbursement for non-burn acute wounds, easing hospital costs and expanding patient access....
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US34960Q3074
Fortress Biotech Inc
FBIO
LISTED
NASDAQ
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
News Preview
Dotinurad is a next-generation URAT1 inhibitor in two Phase 3 clinical trials with potential for best-in-class safety and efficacy...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US14888U1016
Catalyst Pharmaceuticals Inc
CPRX
LISTED
NASDAQ
Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program
News Preview
CORAL GABLES, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing novel medicines for people living with rare and difficult-to-treat diseases, today announced that its Board of Directors...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: CH0334081137
CRISPR Therapeutics AG
CRSP
LISTED
NASDAQ
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
News Preview
ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the acceptance of an abstract for oral presentation at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congre...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: CA71716H1082
PharmaTher Holdings Ltd.
PHRM
LISTED
CSE
PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate Over US$25 Million in Milestone and Profit-Sharing Payments
News Preview
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce that it has entered into a definitive Asset Purchase Agreement (the “Agreement”) for the sale of it...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: ES0167733015
Oryzon Genomics SA
ORY
LISTED
BME
ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors
News Preview
MADRID and CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and European leader in epigenetics, today announced that the European Patent Office (EPO) has issued a Decision to Grant for its patent application EP20712594.9, entitled “Combinations of...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US13463J1016
CAMP4 Therapeutics Corp
CAMP
LISTED
NASDAQ
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
News Preview
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of g...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US01625V1044
Alignment Healthcare Inc
ALHC
LISTED
NASDAQ
Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors
News Preview
Plans to reach nearly 8.3 million Medicare-eligible adults across five states during annual enrollment period, Oct. 15-Dec. 7 Plans to reach nearly 8.3 million Medicare-eligible adults across five states during annual enrollment period, Oct. 15-Dec. 7...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US34960Q3074
Fortress Biotech Inc
FBIO
LISTED
NASDAQ
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
News Preview
MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“Cyprium”), today announced that the U.S. Food and Drug Administration (“FDA”) has issued a Complete Response Letter (“CRL”) relating to the New Drug Application (“NDA”) for CUTX-101 (copper hi...
Themefolio
Profiler
Peergroup
© Newsfile
01.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness QSR Announces the Signing of 1st Real-Estate Location in Montreal, Quebec
News Preview
Toronto, Ontario--(Newsfile Corp. - October 1, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce that Heal Wellness has signed a real-estate location in Montreal, Quebec. The location will be at 6985 Boul. Décarie, Montr...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
News Preview
– Expanding clinical experience and safety profile of ziftomenib support its evaluation in combination with approved FLT3 inhibitors in frontline AML –...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US12529R1077
C4 Therapeutics Inc
CCCC
LISTED
NASDAQ
C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma
News Preview
WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that it has entered into a clinical trial collaboration and supply agreement with Pfizer Inc. Under the terms of the agreement, Pfiz...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US28658R1068
Climb Bio, Inc
CLYM
LISTED
NASDAQ
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer
News Preview
WELLESLEY HILLS, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has strengthened its leadership team with the addition of Susan Altschuller, Ph.D., MBA, as Chief Financial Officer. Susan brings over two de...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US7867001049
Sagimet Biosciences Inc
SGMT
LISTED
NASDAQ
Sagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom Combination
News Preview
SAN MATEO, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that the Company has dosed the first participants in a Phase 1 pharmacokinetic (PK) trial of a comb...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US09077A1060
Biomea Fusion Inc
BMEA
LISTED
NASDAQ
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN CARLOS, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on September 24, 2025, the compensation committee of Biomea’s board of directors granted one new employee non-qualified stock options to purchase 48,000...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US6409791000
Neumora Therapeutics Inc
NMRA
LISTED
NASDAQ
Neumora Therapeutics to Host Virtual R&D Day on October 27
News Preview
WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases, today announced that the Company will host a virtual R&...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US09058V1035
BioCryst Pharmaceuticals Inc
BCRX
LISTED
NASDAQ
BioCryst Completes Sale of European ORLADEYO® (berotralstat) Business
News Preview
– Transaction valued at $250 million, with up to $14 million in future milestones –...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US04335A1051
Arvinas, Inc.
ARVN
LISTED
NASDAQ
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
News Preview
NEW HAVEN, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that two presentations, including one e-poster session and one oral platform presentation, featuring clinical data for ARV-102, an investigati...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: JP3942400007
Astellas Pharma Inc
45030
LISTED
XJPX
Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025
News Preview
- New clinical data across ten accepted abstracts demonstrate significant progress across Astellas' innovative oncology programs -
- Results from the EV-303 trial (also known as KEYNOTE-905) in cisplatin-ineligible patients with muscle invasive bladder cancer se...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix Announces Record-Breaking Presence at EANM 2025
News Preview
MELBOURNE, Australia, Sept. 30, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its record-breaking conference presence with 28 company-related abstract presentations at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held i...
Themefolio
Profiler
Peergroup
© Newsfile
01.10.2025
ISIN: CA74040N1069
Predictmedix AI Inc
PMED
LISTED
CSE
Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform
News Preview
Adaptive "digital brain" designed to cut risk, cost and timelines in the $70-billion clinical-trials market1Toronto, Ontario--(Newsfile Corp. - October 1, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, announced the launch of it...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
MERUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Merus N.V. (NasdaqGM: MRUS) to Genmab A/S (NasdaqGS: GMAB). Under the terms of the proposed transaction, shareholders of Merus will receive $97.00 in cash for each share of Merus that they ow...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US29251M1062
Enanta Pharmaceuticals Inc
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced the pricing of an upsized underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $10.00 per share. All of the shares are b...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $2.5 billion aggregate principal amount (the “Offering”) of the following notes:
$500 million aggregate principal amount of its 4.200% senior notes due 2031 (the “2031 notes”) at the issue price of 99.874% of their principal amount;...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNO
News Preview
NEW YORK, Sept. 30, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf o...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH
News Preview
LOS ANGELES, Sept. 30, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. S...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on September 30, 2025 (the “Grant Date”) that were approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 8 indi...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
